CLINICAL_TRIALS
trial_result
· 2017-08-21
Clinical Trial Update: 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) [Phase 2]
Summary
Phase 2 clinical trial update for neovascular age-related macular degeneration; the study was terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2017-08-21